Regeneron Pharmaceuticals Inc (REGN) — Technical state
As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Trending — Above its 20-, 50- and 200-day — still in an uptrend. (as of 2026-11-13)
- Trend: Regeneron Pharmaceuticals Inc trades 17.1% above its 50-day and 27.9% above its 200-day moving average. (as of 2026-11-13)
- Index seat: HALO Growth 100
Regeneron discovers, develops, manufactures and sells medicines across eye disease, immune and inflammatory conditions, cardiovascular and metabolic disorders, neurological and infectious disease, rare disease, cancer and blood disorders. Its marketed products include an eye injection for macular degeneration and related retinal conditions, an injection for atopic dermatitis and asthma, a skin-cancer treatment, a cholesterol-lowering injection and a rheumatoid arthritis treatment.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the REGN overview. Research diary readings, not advice.
Above its 20-, 50- and 200-day — still in an uptrend.
The moving-average stack
- vs 20-day+8.7%
- vs 50-day+17.1%
- vs 200-day+27.9%
- 52-week band3.7% off the high · +77% off the low
- Streak1 consecutive up session
- Stochastic%K 81.2 · %D 75 · up cross
Continue: the REGN chart & overview · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-13
Quick answers
What is the current Closelooknet signal on REGN?
Trending — Above its 20-, 50- and 200-day — still in an uptrend. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is REGN above its 50-day and 200-day moving averages?
As of 2026-11-13, Regeneron Pharmaceuticals Inc trades +17.1% above its 50-day and +27.9% above its 200-day average, with the 20-day +8.7% away.
How far is REGN from its 52-week high?
3.7% below the 52-week high and 77% above the 52-week low, as of 2026-11-13.
Mentioned on Closelooknet
Where REGN appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- WISE.L Wise plc
- DECK Deckers Outdoor Corporation
- LLY Eli Lilly and Company
- DXCM DexCom Inc
- TOST Toast Inc
- HDB HDFC Bank Limited ADR
- VRSK Verisk Analytics Inc
- GMED Globus Medical
- IDXX IDEXX Laboratories Inc
- DB1.DE Deutsche Börse AG
- ELF ELF Beauty Inc
- FAST Fastenal Company
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- PTGX Protagonist Therapeutics Incindustry
- BION.SW BB Biotech AGindustry
- REPL Replimune Group Incindustry
- VCEL Vericel Corp Ordindustry